NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors
Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors

NCT06328127

RecruitingNA

Sponsor: Brigham and Women's Hospital

Conditions: Hematopoietic Stem Cell Transplant

Interventions: PATH

Countries: United States

This randomized clinical trial is evaluating the impact of a positive psychology intervention (PATH) on anxiety symptoms, depression symptoms, and quality of life in survivors of hematopoietic stem cell transplant (HSCT) compared to usual care.

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Adult patients (aged 18 years and older) undergoing allogeneic HSCT and are approaching 100-days post-HSCT
* Ability to speak, read, and respond to questions in English or Spanish to complete study procedures
* Access to a basic telephone

Exclusion Criteria:

* Patients who underwent allogeneic HSCT for benign hematologic conditions
* Patients with severe psychiatric or cognitive conditions, such as dementia, determined by their transplant oncologist to make them unable to provide informed consent or comply with study procedures
Locations (3)
  • Tampa, Florida, United States
  • Boston, Massachusetts, United States
  • Durham, North Carolina, United States